Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Xetra  >  Bayer AG    BAYN   DE000BAY0017

BAYER AG (BAYN)

Real-time Quote. Real-time Tradegate - 09/27 09:00:18 pm
88.953 EUR   -0.28%
09/26 NEW CLINICAL GU : -- Iberogast™ recommended for the treatment ..
09/26DJLanxess Shares Rise on Acquisition of Chemtura
09/25 POLITICAL NOTES : Garamendi sends condolences
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Bayer AG : EARNINGS FORECAST TABLE : Bayer 4Q 2012

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/22/2013 | 02:32pm CEST

FRANKFURT--The following is a summary of analysts' forecasts for Bayer AG (BAYN.XE) fourth-quarter results, based on a poll of 10 analysts conducted by Dow Jones Newswires (figures in million euros, EPS, dividend and target price in euro, according to IFRS). Earnings figures are scheduled to be released February 28.

=== 
 
                          EBITDA   EBITDA   EBIT    EBIT 
4th Quarter        Sales    adj.    rep.    adj.  reported 
 
AVERAGE            9,726   1,811   1,585   1,092     901 
Prev. Year         9,191   1,541   1,415     844     629 
+/- in %            +5.8     +18     +12     +29     +43 
 
MEDIAN             9,743   1,821   1,585   1,102     841 
Maximum            9,905   1,893   1,633   1,191   1,053 
Minimum            9,536   1,707   1,536     970     808 
Amount (a)            10      10       2       6       5 
 
Baader Bank        9,725   1,839      --      --      -- 
Credit Suisse      9,793   1,831      --   1,191     966 
Deutsche Bank      9,559   1,869      --   1,135   1,053 
Equinet            9,760   1,820      --      --     838 
Exane BNP Paribas  9,611   1,817      --     970      -- 
J.P. Morgan        9,883   1,821   1,633   1,125      -- 
Nomura             9,536   1,707      --   1,078     808 
UBS                9,840   1,760      --      --      -- 
 
 
 
                  Net attrib.             EPS 
4th Quarter         income      EPS      core 
 
AVERAGE              468       0.55      1.06 
Prev. Year           397       0.48      0.97 
+/- in %             +18        +15      +9.3 
 
MEDIAN               494       0.53      1.06 
Maximum              549       0.66      1.12 
Minimum              332       0.46      1.00 
Amount (a)             8          6        10 
 
Baader Bank          542         --      1.02 
Credit Suisse        466       0.56      1.05 
Deutsche Bank        538         --      1.05 
Equinet               --       0.50      1.08 
Exane BNP Paribas    332         --      1.09 
J.P. Morgan          521       0.63      1.06 
Nomura               413       0.50      1.00 
UBS                   --         --      1.03 
 
 
 
               Target price  Rating                 DPS 2012 
 
AVERAGE               77.27  positive 6     AVERAGE     1.84 
Prev. Quarter         67.20  neutral  3     Prev. Year  1.65 
+/- in %                +15  negative 1     +/- in %     +11 
 
MEDIAN                75.00                 MEDIAN      1.83 
Maximum               90.00                 Maximum     1.94 
Minimum               65.60                 Minimum     1.77 
Amount                    9                 Amount         6 
 
Baader Bank           65.60  Hold                         -- 
Barclays              66.00  Underweight                1.81 
Citigroup             90.00  Buy                        1.85 
Commerzbank           90.00  Buy                          -- 
Credit Suisse         82.80  Outperform                 1.94 
Deutsche Bank         86.00  Buy                        1.77 
Equinet               75.00  Accumulate                 1.85 
Exane BNP Paribas     73.00  Neutral                    1.80 
J.P. Morgan              --  Overweight                   -- 
UBS                   67.00  Neutral                      -- 
=== 

Year-earlier figures are as reported by the company.

(a) Including anonymous estimates from two more institutes.

DJG/voi 

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on BAYER AG
09/26 NEW CLINICAL GUIDELINES : -- Iberogast™ recommended for the treatment of f..
09/26DJLanxess Shares Rise on Acquisition of Chemtura
09/25 POLITICAL NOTES : Garamendi sends condolences
09/24 BAYER : buys Monsanto for $66 bln
09/23 BAYER : Flupyradifurone; Pesticide Tolerances
09/23 BAYER AT EUROTIER 2016 : -- Animal Health and Crop Protection from a single sour..
09/23 BAYER : New scholarships worth EUR 345,000 awarded by Bayer Foundation to promot..
09/22 BAYER : partners Bright Future Fund to improve access to innovative treatment fo..
09/22 MONSANTO : and industry execs defend wave of agribusiness mega-mergers
09/21 MONSANTO : and Bayer defend proposed $66 billion merger
More news
Sector news : Pharmaceuticals - NEC
08:49aDJPFIZER : Scraps Plan to Break Up Company -- WSJ
09/26DJMYLAN : EpiPen Pretax Profits 60% Higher Than Number Told to Congress -- 3rd Upd..
09/26 MYLAN : faces scrutiny over EpiPen profit data shown to Congress
09/26DJPFIZER : Throws Out Plan to Split Into Two Companies -- 2nd Update
09/26DJPfizer Throws Out Plan to Split Into Two Companies
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
12:25p Disney Prepping Twitter Bid
09/26 Monsanto/Bayer Merger Difficult, But Could Send MON Higher
09/22 Biontech Deal Sees Roche Bet On mRNA
09/22 Expect Glaxo To Increase Consumer Focus As Walmsley Takes Driving Seat
09/21 Bayer-Monsanto tie-up pilloried in Germany, U.S.